株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の呼吸器診断市場予測 (2017~2027年):装置・機器、アッセイ・試薬、サービス・ソフトウェア、閉塞型睡眠時無呼吸低呼吸症候群診断検査、画像診断検査、従来の診断検査、分子診断検査

Global Respiratory Diagnostics Market Report 2017-2027: Instruments & Devices, Assays & Reagents, Services & Software, OSA Diagnostics Tests, Imaging Diagnostic Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, Other Tests, Tuberculosis

発行 Visiongain Ltd 商品コード 534095
出版日 ページ情報 英文 197 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=135.68円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

世界の呼吸器診断市場予測 (2017~2027年):装置・機器、アッセイ・試薬、サービス・ソフトウェア、閉塞型睡眠時無呼吸低呼吸症候群診断検査、画像診断検査、従来の診断検査、分子診断検査 Global Respiratory Diagnostics Market Report 2017-2027: Instruments & Devices, Assays & Reagents, Services & Software, OSA Diagnostics Tests, Imaging Diagnostic Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, Other Tests, Tuberculosis
出版日: 2017年06月08日 ページ情報: 英文 197 Pages
概要

世界の呼吸器診断市場は2016年の53億2,000万米ドルからCAGR7.4%で拡大し、2022年には80億米ドルに達すると予測されています。装置・機器サブマーケットが最大市場シェアの57.7%を占め、これにアッセイ、試薬サブマーケットが続きます。

当レポートでは、世界の呼吸器診断市場について調査し、市場の概要と製品・サービス別、検査タイプ別、疾患タイプ別、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 調査の概要

第2章 市場の定義

  • 呼吸器診断とは
  • 呼吸器診断検査
    • 肺機能検査
    • パルスオキシメトリ
    • カプノグラフィ
    • 動脈血液ガス分析
    • 換気血流研究
  • 市場構造

第3章 製品・サービス別市場

  • 装置・機器
  • アッセイ・試薬
  • サービス・ソフトウェア

第4章 検査タイプ別市場

  • 閉塞性睡眠時無呼吸症候群診断検査
  • 画像検査
  • 従来型診断検査
  • 分子診断検査
  • その他

第5章 エンドユーザー別市場

  • 病院/臨床試験所
  • 参照試験所
  • 診療所
  • その他

第6章 疾患タイプ別市場

  • 結核
  • 喘息
  • 肺癌
  • 慢性閉塞性肺疾患
  • その他

第7章 地域別市場

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第8章 促進因子と阻害因子

第9章 主要企業

  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • Abbott
  • ThermoFisher Scientific Inc.
  • Biomerieux SA
  • Alere Inc.
  • Bio-Rad Laboratories, Inc.
  • COSMED
  • Seegene Inc.
  • SDI Diagnostics

第10章 定性的分析

第11章 結論と提言

目次
Product Code: PHA0199

Title:
Global Respiratory Diagnostics Market Report 2017-2027
Instruments & Devices, Assays & Reagents, Services & Software, Obstructive Sleep Apnoea (OSA) Diagnostics Tests, Imaging Diagnostic Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, Other Tests, Tuberculosis, Asthma, Lung Cancer, COPD, Other Diseases, Hospitals, Reference Laboratories, Physician Offices, Other End-Users.

The global respiratory diagnostics market is expected to grow at a CAGR of 7.1% in the first half of the forecast period. The market is expected to grow at a CAGR of 7.4% from 2017-2027. The market is estimated at $5.32bn in 2016 and $8.00bn in 2022. In 2016, The instruments and devices submarket held the largest market share at 57.7%, followed by the assays and reagents submarket at 23.8%.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 197-page report you will receive 56 tables and 118 figures - all unavailable elsewhere.

The 197-page report provides clear detailed insight into the global respiratory diagnostics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Respiratory Diagnostics market forecasts from 2017-2027

This report also breaks down the revenue forecast for the global respiratory diagnostics market by product & service:

  • Instruments and Devices
  • Assays and Reagents
  • Services and Software

The forecast of each submarket is further broken down by region (North America, Europe, Asia-Pacific, RoW)

This report also breaks down the revenue forecast for the global respiratory diagnostics market by test type:

  • Obstructive Sleep Apnoea (OSA) Diagnostic Tests
  • Imaging Tests
  • Traditional Diagnostic Tests
  • Molecular Diagnostic Tests
  • Other test type

The forecast of each submarket is further broken down by region (North America, Europe, Asia-Pacific, RoW)

This report also breaks down the revenue forecast for the global respiratory diagnostics market by end-users:

  • Hospitals/Clinic Laboratories
  • Reference Laboratories
  • Physician Offices
  • Other end-users

The forecast of each submarket is further broken down by region (North America, Europe, Asia-Pacific, RoW)

This report also breaks down the revenue forecast for the global respiratory diagnostics market by disease type:

  • Tuberculosis
  • Asthma
  • Lung Cancer
  • COPD
  • Other diseases

The forecast of each submarket is further broken down by region (North America, Europe, Asia-Pacific, RoW)

This report provides individual revenue forecasts to 2027 for these regional and national markets:

  • North America: the US and Rest of North America
  • Europe: the UK, Germany, France, Spain, Italy, Russia and Rest of Europe
  • Asia-Pacific: China, India, Japan, Rest of Asia-Pacific
  • Rest of the World: Latin America, Middle East and Africa

The forecast of each region is further broken down by product & service, test type, end-users and disease type

  • Our study discusses the drivers and restraints that affect the global respiratory diagnostics market. Our study also discusses Porter's Five Forces analysis that influence the global respiratory diagnostics market
  • Our study discusses the selected leading companies that are the major players in the respiratory diagnostics industry.

Visiongain's study is intended for anyone requiring commercial analyses for the global respiratory diagnostics market. You find data, trends and predictions.

Buy our report today Global Respiratory Diagnostics Market Report 2017-2027: Instruments & Devices, Assays & Reagents, Services & Software, Obstructive Sleep Apnoea (OSA) Diagnostics Tests, Imaging Diagnostic Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, Other Tests, Tuberculosis, Asthma, Lung Cancer, COPD, Other Diseases, Hospitals, Reference Laboratories, Physician Offices, Other End-Users.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Respiratory Diagnostics Market Overview
  • 1.2. Overview of Findings
  • 1.3. Structure of the Report
  • 1.4. Global Respiratory Diagnostics Market Segmentation
  • 1.5. Why You Should Read This Report
  • 1.6. Key Questions Answered by This Analytical Report
  • 1.7. Who is This Report For?
  • 1.8. Methodology
  • 1.9. Frequently Asked Questions (FAQ)
  • 1.10. Associated Visiongain Reports
  • 1.11. About Visiongain

2. Respiratory Diagnostics Market Definition

  • 2.1. What is Respiratory Diagnostics?
  • 2.2. Respiratory Diagnostics Tests
    • 2.2.1. Pulmonary Function Tests
    • 2.2.2. Pulse Oximetry
    • 2.2.3. Capnography
    • 2.2.4. Arterial Blood Gas (ABG) Analysis
    • 2.2.5. Ventilation Perfusion Studies
  • 2.3. Respiratory Diagnostics Market Structure

3. Global Respiratory Diagnostics by Product and Service 2016-2027

  • 3.1. Instruments and Devices Submarket Forecast & Analysis 2017-2027
  • 3.2. Assays and Reagents Submarket Forecast & Analysis 2017-2027
  • 3.3. Services and Software Submarket Forecast & Analysis 2017-2027

4. Global Respiratory Diagnostics by Test Type 2016-2027

  • 4.1. Obstructive Sleep Apnea (OSA) Diagnostic Tests Submarket Forecast & Analysis 2017-2027
  • 4.2. Imaging Tests Submarket Forecast & Analysis 2017-2027
  • 4.3. Traditional Diagnostic Tests Submarket Forecast & Analysis 2017-2027
  • 4.4. Molecular Diagnostic Tests Submarket Forecast & Analysis 2017-2027
  • 4.5. Other Test Type Submarket Forecast & Analysis 2017-2027

5. Global Respiratory Diagnostics Market by End-Users 2016-2027

  • 5.1. Hospitals/Clinical Laboratories Submarket Forecast & Analysis 2017-2027
  • 5.2. Reference Laboratories Submarket Forecast & Analysis 2017-2027
  • 5.3. Physician Offices Submarket Forecast & Analysis 2017-2027
  • 5.4. Other End-Users Submarket Forecast & Analysis 2017-2027

6. Global Respiratory Diagnostics by Disease Types 2016-2027

  • 6.1. Tuberculosis Submarket Forecast & Analysis 2017-2027
  • 6.2. Asthma Submarket Forecast & Analysis 2017-2027
  • 6.3. Lung Cancer Submarket Forecast & Analysis 2017-2027
  • 6.4. Chronic Obstructive Pulmonary Disease (COPD) Submarket Forecast & Analysis 2017-2027
  • 6.5. Other Diseases Submarket Forecast & Analysis 2017-2027

7. Regional Respiratory Diagnostics Market Forecasts 2016-2027

  • 7.1. North American Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.1.1. U.S. Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.1.2. Rest of North America Respiratory Diagnostics Market Forecasts 2017-2027
  • 7.2. North American Respiratory Diagnostics Market Forecasts by Product and Service 2017-2027
  • 7.3. North American Respiratory Diagnostics Market Forecasts by Test Type 2017-2027
  • 7.4. North American Respiratory Diagnostics Market Forecasts by Disease Type 2017-2027
  • 7.5. North American Respiratory Diagnostics Market Forecasts by End-Users 2017-2027
  • 7.6. Europe Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.6.1. France Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.6.2. Germany Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.6.3. U.K. Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.6.4. Spain Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.6.5. Italy Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.6.6. Russia Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.6.7. Rest of Europe Respiratory Diagnostics Market Forecasts 2017-2027
  • 7.7. European Respiratory Diagnostics Market Forecasts by Product and Service 2017-2027
  • 7.8. European Respiratory Diagnostics Market Forecasts by Test Type 2017-2027
  • 7.9. European Respiratory Diagnostics Market Forecasts by Disease Type 2017-2027
  • 7.10. European Respiratory Diagnostics Market Forecasts by End-Users 2017-2027
  • 7.11. Asia-Pacific Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.11.1. China Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.11.2. India Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.11.3. Japan Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.11.4. Rest of Asia-Pacific (APAC) Respiratory Diagnostics Market Forecasts 2017-2027
  • 7.12. Asia-Pacific Respiratory Diagnostics Market Forecasts by Product and Service 2017-2027
  • 7.13. Asia-Pacific Respiratory Diagnostics Market Forecasts by Test Type 2017-2027
  • 7.14. Asia-Pacific Respiratory Diagnostics Market Forecasts by Disease Type 2017-2027
  • 7.15. Asia-Pacific Respiratory Diagnostics Market Forecasts by End-Users 2017-2027
  • 7.16. Rest of the World (RoW) Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.16.1. Latin America Respiratory Diagnostics Market Forecasts 2017-2027
    • 7.16.2. Middle East and Africa Respiratory Diagnostics Market Forecasts 2017-2027
  • 7.17. Rest of the World (RoW) Respiratory Diagnostics Market Forecasts by Product and Service 2017-2027
  • 7.18. Rest of the World (RoW) Respiratory Diagnostics Market Forecasts by Test Type 2017-2027
  • 7.19. Rest of the World (RoW) Respiratory Diagnostics Market Forecasts by Disease Type 2017-2027
  • 7.20. Rest of the World (RoW) Respiratory Diagnostics Market Forecasts by End-Users 2017-2027

8. Drivers & Restraints of the Respiratory Diagnostics Market

  • 8.1. Drivers and Restraints of the Respiratory Diagnostics Market 2017-2027
  • 8.2. Drivers of the Respiratory Diagnostics Market
    • 8.2.1. Increasing Prevalence of Respiratory Disorders
    • 8.2.2. Exponential Rise in Geriatric Population
    • 8.2.3. Technological Advancements
  • 8.3. Restraints of the Respiratory Diagnostics Market
    • 8.3.1. Regulatory Landscape
    • 8.3.2. Reduction in the Usage of Respiratory Diagnostics Tests to Cut Healthcare Spending

9. Leading Companies in the Respiratory Diagnostics Market

  • 9.1. Koninklijke Philips N.V.
    • 9.1.1. Koninklijke Philips N.V. Business Overview
    • 9.1.2. Koninklijke Philips N.V. Product Portfolio
    • 9.1.3. Koninklijke Philips N.V. Financial Overview
    • 9.1.4. Koninklijke Philips N.V. Corporate Strategy
  • 9.2. Becton, Dickinson and Company
    • 9.2.1. Becton, Dickinson and Company Business Overview
    • 9.2.2. Becton, Dickinson and Company Product Portfolio
    • 9.2.3. Becton, Dickinson and Company Financial Overview
    • 9.2.4. Becton, Dickinson and Company Corporate Strategy
  • 9.3. Abbott
    • 9.3.1. Abbott Business Overview
    • 9.3.2. Abbott Product Portfolio
    • 9.3.3. Abbott Financial Overview
    • 9.3.4. Abbott Corporate Strategy
  • 9.4. ThermoFisher Scientific Inc.
    • 9.4.1. ThermoFisher Scientific Inc. Business Overview
    • 9.4.2. ThermoFisher Scientific Inc. Product Portfolio
    • 9.4.3. ThermoFisher Scientific Inc. Financial Overview
    • 9.4.4. ThermoFisher Scientific Inc. Corporate Strategy
  • 9.5. Biomérieux SA
    • 9.5.1. Biomérieux SA Business Overview
    • 9.5.2. Biomérieux SA Product Portfolio
    • 9.5.3. Biomérieux SA Financial Overview
    • 9.5.4. Biomérieux SA Corporate Strategy
  • 9.6. Alere Inc.
    • 9.6.1. Alere Inc. Business Overview
    • 9.6.2. Alere Inc. Product Portfolio
    • 9.6.3. Alere Inc. Financial Overview
    • 9.6.4. Alere Inc. Corporate Strategy
  • 9.7. Bio-Rad Laboratories, Inc.
    • 9.7.1. Bio-Rad Laboratories, Inc. Business Overview
    • 9.7.2. Bio-Rad Laboratories, Inc. Product Portfolio
    • 9.7.3. Bio-Rad Laboratories, Inc. Financial Overview
    • 9.7.4. Bio-Rad Laboratories Inc. Corporate Strategy
  • 9.8. COSMED
    • 9.8.1. COSMED Business Overview
    • 9.8.2. COSMED Product Portfolio
    • 9.8.3. COSMED Financial Overview
    • 9.8.4. COSMED Corporate Strategy
  • 9.9. Seegene Inc.
    • 9.9.1. Seegene Inc. Business Overview
    • 9.9.2. Seegene Inc. Product Portfolio
    • 9.9.3. Seegene Inc. Financial Overview
    • 9.9.4. Seegene Inc. Corporate Strategy
  • 9.10. SDI Diagnostics
    • 9.10.1. SDI Diagnostics Business Overview
    • 9.10.2. SDI Diagnostics Product Portfolio
    • 9.10.3. SDI Diagnostics Financial Overview

10. Qualitative Analysis of the Respiratory Diagnostics Market

  • 10.1. Porter's Five Forces Analysis of the Respiratory Diagnostics Market
  • 10.2. Rivalry Among Competitors [High]
  • 10.3. Threat of New Entrants [Medium]
  • 10.4. Power of Suppliers [Low]
  • 10.5. Power of Buyers [Medium]
  • 10.6. Threat of Substitutes [Medium]

11. Conclusions

  • 11.1. Current Leading Respiratory Diagnostics Segments
    • 11.1.1. Leading Respiratory Diagnostics Companies
    • 11.1.2. Leading Regional Markets
    • 11.1.3. Emerging Respiratory Diagnostics Markets
  • Glossary
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Tables:

  • Table 3.1: Respiratory Diagnostics Submarkets by Product and Service: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 3.2: Instruments and Devices Markets by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 3.3: Assays and Reagents markets by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 3.4: Services and Software Markets by Region: Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.1: Respiratory Diagnostics Submarkets by Test Type: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 4.2: Obstructive Sleep Apnea (OSA) Diagnostic Tests Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 4.3: Imaging Tests Markets by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 4.4: Traditional Diagnostic Tests Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 4.5: Molecular Diagnostic Tests Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 4.5: Other Test Type Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 5.1: Respiratory Diagnostics Submarkets by End-Users: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 5.2: Hospitals/Clinical Laboratories Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 5.3: Reference Laboratories Markets by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 5.4: Physician Offices Markets by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 5.5: Other End-Users Markets by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 6.1: Respiratory Diagnostics Submarkets by Disease Types: Forecast ($bn, AGR%, CAGR%)
  • Table 6.2: Tuberculosis Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 6.3: Asthma Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 6.4: Lung Cancer Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 6.5: Chronic Obstructive Pulmonary Disease (COPD) Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 6.6: Other Diseases Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
  • Table 7.1: Leading National Respiratory Diagnostics Market Forecast 2016-2021 ($bn, AGR% CAGR%)
  • Table 7.2: Leading National Respiratory Diagnostics Market Forecast 2022-2027 ($bn, AGR% CAGR%)
  • Table 7.3: Regional Respiratory Diagnostics Market Forecasts ($bn, AGR% CAGR%), 2016-2027
  • Table 7.4: U.S. Respiratory Diagnostics Market Forecasts by Type: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.5: Rest of North America Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
  • Table 7.6: North American Respiratory Diagnostics Market by Product and Service: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.7: North American Respiratory Diagnostics Market Forecasts by Test Type: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.8: North American Respiratory Diagnostics Market by Disease Type: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.9: North American Respiratory Diagnostics Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.10: France Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
  • Table 7.11: Germany Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
  • Table 7.12: U.K. Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
  • Table 7.13: Spain Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
  • Table 7.14: Italy Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
  • Table 7.15: Russia Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
  • Table 7.16: Rest of Europe Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
  • Table 7.17: European Respiratory Diagnostics Market by Product and Service: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.18: European Respiratory Diagnostics Market by Test Type: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.19: European Respiratory Diagnostics Market by Test Type: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.20: European Respiratory Diagnostics Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.21: China Respiratory Diagnostics Market: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.22: India Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
  • Table 7.23: Japan Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
  • Table 7.24: Rest of Asia-Pacific (APAC) Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
  • Table 7.25: Asia-Pacific Respiratory Diagnostics Market by Product and Service: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.26: Asia-Pacific Respiratory Diagnostics Market by Test Type: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.27: Asia-Pacific Respiratory Diagnostics Market Forecasts by Test Type: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.28: Asia-Pacific Respiratory Diagnostics Market Forecasts by End-Users: Forecast ($bn, AGR% CAGR%) 2016-2027
  • Table 7.29: Latin America Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
  • Table 7.30: Middle East and Africa Respiratory Diagnostics Market: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.31: RoW Respiratory Diagnostics Market Forecasts, By Product and Service ($bn, AGR% CAGR%) 2016-2027
  • Table 7.32: RoW Respiratory Diagnostics Market Forecasts by Test Type: Forecast ($bn, AGR% CAGR%), 2016-2027
  • Table 7.33: RoW Respiratory Diagnostics Market Forecasts by Diseases Type: Forecast ($bn, AGR% CAGR%) 2016-2027
  • Table 7.34: RoW Respiratory Diagnostics Market Forecasts, By End-Users ($bn, AGR% CAGR%) 2016-2027
  • Table 8.1: Top 5 Global Respiratory Diseases According to International Respiratory Societies, 2013

List of Figures:

  • Figure 1.1: Global Respiratory Diagnostics Market Segmentation Overview
  • Figure 2.1: Global Respiratory Diagnostics Market Segmentation Overview, 2017
  • Figure 3.1: Global Respiratory Diagnostics Market by Product and Service: (% Share), 2016
  • Figure 3.2: Respiratory Diagnostics Submarkets by Product and Service: Forecast ($bn), 2016-2027
  • Figure 3.3: Instruments and Devices Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 3.4: Global Instruments & Devices Market by Region: Forecast ($bn), 2016-2027
  • Figure 3.5: Instruments and Devices Market Share by Region: (% Share), 2016-2027
  • Figure 3.6: Assays and Reagents Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 3.7: Global Assays and Reagents Market by Region: Forecast ($bn) 2016-2027
  • Figure 3.8: Assays and Reagents Market Share by Region: (% Share), 2016-2027
  • Figure 3.9: Services and Software Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 3.10: Global Services & Software Market by Region: Revenue ($bn), 2016-2027
  • Figure 3.11: Global Services & Software Market Share by Region: (% Share), 2016-2027
  • Figure 4.1: Global Respiratory Diagnostics Market by Test Type: (% Share), 2016
  • Figure 4.2: Respiratory Diagnostics Submarkets by Test Type: Forecast ($bn), 2016-2027
  • Figure 4.3: Obstructive Sleep Apnea (OSA) Diagnostic Tests Market Forecast: AGR(%), 2017-2027
  • Figure 4.4: Global OSA Diagnostic Tests Market by Region: Forecast ($bn), 2016-2027
  • Figure 4.5: Global OSA Diagnostic Tests Market Share by Region: (% Share), 2016-2027
  • Figure 4.6: Imaging Tests Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 4.7: Global Imaging Diagnostic Tests Market by Region: Forecast ($bn), 2016-2027
  • Figure 4.8: Global Imaging Diagnostic Tests Market Share by Region: (% Share), 2016-2027
  • Figure 4.9: Traditional Diagnostic Tests Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 4.10: Global Traditional Diagnostic Tests Market by Region: Forecast ($bn), 2016-2027
  • Figure 4.11: Global Traditional Diagnostic Tests Market Share by Region: (% Share), 2016-2027
  • Figure 4.12: Molecular Diagnostic Tests Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 4.13: Global Molecular Diagnostic Tests Market by Region: Forecast ($bn), 2016-2027
  • Figure 4.14: Global Molecular Diagnostic Tests Market Share by Region: (% Share), 2016-2027
  • Figure 4.15: Other Test Type Submarkets Forecast: AGR(%), 2017-2027
  • Figure 4.16: Global Other Diagnostic Test Type Market by Region: Revenue ($bn), 2016-2027
  • Figure 4.17: Global Other Diagnostic Test Type Market Share by Region: (% Share), 2016-2027
  • Figure 5.1: Global Respiratory Diagnostics Market by End-Users: (% Share), 2016
  • Figure 5.2: Respiratory Diagnostics Submarkets by End-Users: Forecast ($bn), 2016-2027
  • Figure 5.3: Hospital/Clinical Laboratories Market Forecasts: AGR(%), 2017-2027
  • Figure 5.4: Global Hospitals/Clinical Laboratories Market by Region: Forecast ($bn), 2016-2027
  • Figure 5.5: Global Hospitals/Clinical Laboratories Market Share by Region: (% Share), 2016-2027
  • Figure 5.6: Reference Laboratories Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 5.7: Global Reference Laboratories Market by Region: Forecast ($bn), 2016-2027
  • Figure 5.8: Global Reference Laboratories Market Share by Region: (% Share), 2016-2027
  • Figure 5.9: Physician Offices Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 5.10: Global Physician Offices Market by Region: Forecast ($bn), 2016-2027
  • Figure 5.11: Global Physician Offices Market Share by Region: (% Share), 2016-2027
  • Figure 5.12: Other End-Users Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 5.13: Global Other End-Users Market by Region: Revenue ($bn), 2016-2027
  • Figure 5.14: Global Other End-Users Market Share by Region: (% Share), 2016-2027
  • Figure 6.1: Global Respiratory Diagnostics Market by Disease Types: (% Share), 2016
  • Figure 6.2: Respiratory Diagnostics Submarkets by Disease Types: Forecast ($bn), 2016-2027
  • Figure 6.3: Tuberculosis Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 6.4: Global Tuberculosis Disease Market by Region: Forecast ($bn), 2016-2027
  • Figure 6.5: Global Tuberculosis Disease Market Share by Region: (% Share), 2016-2027
  • Figure 6.6: Asthma Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 6.7: Global Asthma Disease Market by Region: Forecast ($bn), 2016-2027
  • Figure 6.8: Global Asthma Disease Market Share by Region: (% Share), 2016-2027
  • Figure 6.9: Lung Cancer Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 6.10: Global Lung Cancer Disease Market by Region: Forecast ($bn), 2016-2027
  • Figure 6.11: Global Lung Cancer Disease Market Share by Region: (% Share), 2016-2027
  • Figure 6.12: Chronic Obstructive Pulmonary Disease (COPD) Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 6.13: Global Chronic Obstructive Pulmonary Disease (COPD) Market by Region: Forecast ($bn), 2016-2027
  • Figure 6.14: Global Chronic Obstructive Pulmonary Disease (COPD) Market Share by Region: (% Share), 2016-2027
  • Figure 6.15: Other Diseases Submarkets Forecasts: AGR(%), 2017-2027
  • Figure 6.16: Global Other Diseases Market by Region: Forecast ($bn), 2016-2027
  • Figure 6.17: Global Other Diseases Market Share by Region: (% Share) , 2016-2027
  • Figure 7.1: Regional Respiratory Diagnostic Markets Forecasts ($bn), 2017-2027
  • Figure 7.2: North American Respiratory Diagnostics Market Share Analysis by Country ($bn, AGR%), 2016
  • Figure 7.3: U.S. Respiratory Diagnostics Market : Forecasts ($bn), 2016-2027
  • Figure 7.4: Rest of North America Respiratory Diagnostics Market : Forecasts ($bn), 2016-2027
  • Figure 7.5: North American Respiratory Diagnostics Market by Test Type: Forecast ($bn), 2016-2027
  • Figure 7.6: North American Respiratory Diagnostics Market by Disease Type: Forecast ($bn), 2016-2027
  • Figure 7.7: North American Respiratory Diagnostics Market by End-Users: Forecast ($bn), 2016-2027
  • Figure 7.8: European Respiratory Diagnostics Market Share by Country: (%Share), 2016
  • Figure 7.9: France Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027
  • Figure 7.10: Germany Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027
  • Figure 7.11: U.K. Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027
  • Figure 7.12: Spain Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027
  • Figure 7.13: Italy Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027
  • Figure 7.14: Russia Respiratory Diagnostics Market : Forecasts ($bn), 2016-2027
  • Figure 7.15: Rest of Europe Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027
  • Figure 7.16: European Respiratory Diagnostics Market by Product and Service: Forecast ($bn), 2016-2027
  • Figure 7.17: European Respiratory Diagnostics Market by Test Type: Forecast ($bn), 2016-2027
  • Figure 7.18: European Respiratory Diagnostics Market by Disease Type: Forecast ($bn), 2016-2027
  • Figure 7.19: European Respiratory Diagnostics Market by End-Users: Forecast ($bn), 2016-2027
  • Figure 7.20: Asia-Pacific Respiratory Diagnostics Market by Country: Forecast ($bn), 2016
  • Figure 7.21: China Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027
  • Figure 7.22: India Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027
  • Figure 7.23: Japan Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027
  • Figure 7.24: Rest of Asia-Pacific (APAC) Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027
  • Figure 7.25: Asia-Pacific Respiratory Diagnostics Market by Product and Service: Forecast ($bn), 2016-2027
  • Figure 7.26: Asia-Pacific Respiratory Diagnostics Market Revenue Analysis by Test Type: Forecast ($bn), 2016-2027
  • Figure 7.27: Asia-Pacific Respiratory Diagnostics Market Revenue Analysis by Disease Type: Forecast ($bn), 2016-2027
  • Figure 7.28: Asia-Pacific Respiratory Diagnostics Market Revenue Analysis by End-Users: Forecast ($bn), 2016-2027
  • Figure 7.29: Rest of the World (RoW) Respiratory Diagnostics Market Share Analysis by Country: (% Share), 2016-2027
  • Figure 7.30: Latin America Respiratory Diagnostics Market: Forecast ($bn), 2016-2027
  • Figure 7.31: Middle East and Africa Respiratory Diagnostics Market: Forecast ($bn), 2016-2027
  • Figure 7.32: RoW Respiratory Diagnostics Market Revenue Analysis by Product and Service: Forecast ($bn), 2016-2027
  • Figure 7.33: RoW Respiratory Diagnostics Market Revenue Analysis by Test Type: Forecast ($bn), 2016-2027
  • Figure 7.34: RoW Respiratory Diagnostics Market Revenue Analysis by Disease Type: Forecast ($bn), 2016-2027
  • Figure 7.35: RoW Respiratory Diagnostics Market Revenue Analysis by End-Users: Forecast ($bn), 2016-2027
  • Figure 8.1: Respiratory Diagnostics Market: Drivers and Restraints, 2017-2027
  • Figure 8.2: Global Ageing Population, 2000 vs 2050
  • Figure 9.1: Koninklijke Philips N.V., 2016 Annual Revenue by Business Segments
  • Figure 9.2: Koninklijke Philips N.V., Annual Revenue 2012-2016 ($m)
  • Figure 9.3: Becton, Dickinson and Company 2016 Annual Revenue by Business Segments
  • Figure 9.4: Becton, Dickinson and Company Annual Revenue 2012-2016 ($m)
  • Figure 9.5: Abbott 2016 Annual Revenue by Business Segments
  • Figure 9.6: Abbott Annual Revenue 2012-2016 ($m)
  • Figure 9.7: ThermoFisher Scientific Inc. 2016 Annual Revenue by Business Segments
  • Figure 9.8: ThermoFisher Scientific Inc. Annual Revenue 2012- 2016 ( $m)
  • Figure 9.9: Biomérieux SA 2015 Annual Revenue By Business Segments
  • Figure 9.10: Biomérieux SA Annual Revenue (2012-2016) ($m)
  • Figure 9.11: Alere Inc. 2015 Annual Revenue by Business Segments
  • Figure 9.12: Alere Inc. Annual Revenue 2012-2015 ($m)
  • Figure 9.13: Bio-Rad Laboratories, Inc. 2016 Annual Revenue by Business Segments
  • Figure 9.14: Bio-Rad Laboratories, Inc. Annual Revenue 2012-2016 ($m)
  • Figure 10.1: Porter's Five Forces Analysis of the Respiratory Diagnostics Market, 2017-2027
  • Figure 11.1: Global Respiratory Diagnostics Market Analysis: Forecast ($bn), 2016-2027
  • Figure 11.2: Respiratory Diagnostics Market Analysis by Regions: Forecast ($bn), 2016-2027

List of Companies and Organizations Mentioned in the Report:

  • 4Dx Laboratories
  • Abbott Laboratories
  • Affymetrix Inc.
  • Alere, Inc.
  • Apax Partners
  • AU Health
  • Augusta University
  • Australian Pharmacy Sleep Services (APSS)
  • Becton, Dickinson and Company
  • Biomérieux SA
  • Bio-Rad Laboratories, Inc.
  • CareFusion Corporation
  • Clinical Laboratory Improvement Amendments (CLIA)
  • COSMED
  • Diagnostics Development
  • European Commission
  • European Union
  • Food and Drug Administration (FDA)
  • Global Alliance against Chronic Respiratory Disease
  • Goldman Sachs & Co. LLC
  • Hologic
  • Illumina Inc.
  • Inpeco
  • International Respiratory Societies
  • Inverness Medical Canada, Inc.
  • J.P. Morgan Securities LLC
  • JLL Partners
  • Koninklijke Philips N.V.
  • Life Technologies Corp.
  • Morgan Stanley & Co. LLC
  • National Institute on Aging (NIA)
  • P&M Venge
  • Patheon
  • RainDance Technologies, Inc.
  • ResApp Health Limited
  • Respiratory Technologies, Inc. (RespirTech)
  • Royal DSM
  • Samsung
  • SDI Diagnostics
  • Seegene Inc.
  • Seegene Technologies, Inc.
  • Skadden, Arps, Slate, Meagher & Flom LLP
  • Skolkovo Innovation Center
  • SPD
  • Thermo Fisher Scientific Inc.
  • Uppsala University
  • Vyaire Medical
  • Wachtell, Lipton, Rosen & Katz
  • World Health Organizations (WHO)